Epidural Electrical Stimulation for Spinal Cord Injury Patients and Corticospinal Motor Circuit Improvement
1 other identifier
interventional
20
1 country
1
Brief Summary
The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2024
CompletedFirst Submitted
Initial submission to the registry
June 7, 2024
CompletedFirst Posted
Study publicly available on registry
June 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
September 19, 2025
September 1, 2025
2.7 years
June 7, 2024
September 16, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Electroencephalography and Electromyography
To measure activity in the brain
To measure assessing change between pre-implant and every 3 months until 24 months.
Electromyographic analysis
Average of 5-repetitive EMG activity for each superficial component of muscles from a five-second ramp contraction to the end of a ten-second rest
To measure assessing change between pre-implant and every 3 months until 24 months.
Single transcranial magnetic stimulation
To evaluate the function of corticospinal tract nerve conduction
To measure assessing change between pre-implant and every 3 months until 24 months.
Motion Analysis
To evaluate the angles that can be achieved at each joint of the upper limbs
To measure assessing change between pre-implant and every 3 months until 24 months.
Functional Test
To evaluate gait for subjects who can walk by assistive device or independently
To measure assessing change between pre-implant and every 3 months until 24 months.
Secondary Outcomes (9)
American Spinal Injury Association (ASIA-2019) Impairment Scale
To measure assessing change between pre-implant and every 3 months until 24 months.
Modified Ashworth scale
To measure assessing change between pre-implant and every 3 months until 24 months.
Barthel Index
To measure assessing change between pre-implant and every 3 months until 24 months.
World Health Organization Quality of Life Brief Version
To measure assessing change between pre-implant and every 3 months until 24 months.
Spinal Cord Independence Measure
To measure assessing change between pre-implant and every 3 months until 24 months.
- +4 more secondary outcomes
Study Arms (1)
Epidural Stimulator
EXPERIMENTALParticipants will have a 16-electrode epidural array implanted in the C4-C7 and T11-L2 areas of the spinal cord. Following a 2 weeks recovery period, patients will engage in a structured training of physical rehabilitation and electrical stimulation.
Interventions
Participants will have a 16-electrode epidural array implanted in the C4-C7 and T11-L2 areas of the spinal cord. Following a 2 weeks recovery period, patients will engage in a structured training of physical rehabilitation and electrical stimulation.
Eligibility Criteria
You may qualify if:
- SCI ASIA: A, B, C,D
- Between 20 and 70 year of age
- \>1 year post SCI
- Complete or incomplete spinal cord injury.
- Expected will undergo spinal cord stimulation surgery.
- Continued rehabilitation after surgery for spinal cord injury.
- Able to comply with procedures and follow up.
- Stable medical condition without cardiopulmonary disease or dysautonomia that would - contraindicate participation in lower extremity rehabilitation or testing activities
You may not qualify if:
- Have significant cognitive impairment (MMSE\<24).
- Had a mental illness within one year or been treated in the past.
- Have Major depressive disorder.
- Active cancer diagnosis.
- Painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or urinary tract infection that might interfere with stand or step training.
- Cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention.
- Unable to read and/or comprehend the consent form.
- Have concerns about this trial and do not sign consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Buddhist Tzu Chi Medical Foundation Hualien Tzu Chi Hospital
Hualien City, 970, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheng-Tzung Tsai, M.D., Ph.D.
Hualien Tzu Chi General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2024
First Posted
June 12, 2024
Study Start
April 30, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
September 19, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share